We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Staphylococcal Pathogens Assessed in Periprosthetic Joint Infections

By LabMedica International staff writers
Posted on 04 Nov 2016
Periprosthetic joint infections (PJI) are the main complication of knee and hip prosthetic arthroplasty and between 1% and 3% of patients undergoing prosthesis implantation are affected by these infections.

The characteristics of periprosthetic joint infection (PJI) due to Staphylococcus lugdunensis have been assessed and compared to the characteristics of PJI due to Staphylococcus aureus and Staphylococcus epidermidis. More...
S. lugdunensis is a coagulase-negative staphylococci (CoNS) that is considered part of the normal flora of human skin, as are other CoNS species.

Medical microbiologists at the Hôpital J. Ducuing (Toulouse, France) conducted a retrospective and descriptive study from 2000 to 2014, including patients from three orthopedic centers in the same area. Eighty-eight consecutive cases of monomicrobial staphylococcal PJI were analyzed; 28 due to S. lugdunensis, 30 to S. aureus, and 30 S. epidermidis. The diagnosis of PJI was established in the presence of one major criterion or two minor criteria: the major criteria were at least two positive periprosthetic cultures with phenotypically identical organisms, or a sinus tract communicating with the joint; minor criteria were a C-reactive protein (CRP) value greater than 10 mg/L and a histological analysis of periprosthetic tissue confirming a septic process.

For each suspected site, hard and soft tissue specimens were collected in sterile glass vials and articular fluid was inoculated into blood culture bottles. After inoculation into culture media, these were observed daily for microbial growth. Bacteriological criteria for a positive diagnosis of infection were the following: at least one positive sample for S. aureus-positive cultures; at least two positive samples for S. epidermidis- and S. lugdunensis-positive cultures. In the case of a positive culture, identification was performed by the Vitek 2 automated technique or the API Staph manual technique.

Clinical symptoms were more often reported in the S. lugdunensis group, and the median delay between surgery and infection was shorter for the S. lugdunensis group than for the S. aureus and S. epidermidis groups. As regards antibiotic susceptibility, the S. lugdunensis strains were susceptible to antibiotics and 61% of the patients could be treated with levofloxacin + rifampicin. The outcome of the PJI was favorable for 89% of patients with S. lugdunensis, 83% with S. aureus, and 97% with S. epidermidis. Nine unfavorable outcomes were reported in the total population.

The authors concluded that S. lugdunensis is classified as a CoNS, but the clinical features of S. lugdunensis PJI, the early aspect of the infection, and the relapses observed are similar to those in S. aureus PJI. Regarding the microbiological diagnosis, the species of CoNS in PJI must be identified precisely and treatment adapted to the antibiotic susceptibility, even if only one deep sample is positive in culture. The study was published in the October 2016 issue of the International Journal of Infectious Diseases.

Related Links:
Hôpital J. Ducuing



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.